Lung cancer trials in Australia
164 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleStudy of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
- Where
- Clayton
- Age
- 18 years to 99 years
- People
- 160 worldwide
- Run by
- Amgen
See details and how to joinNCT07531095 · EU 2025-522888-15-00 - Phase 1Taking peopleA First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
- Where
- Southport, Waratah
- Age
- 18 years to 75 years
- People
- 299 worldwide
- Run by
- Huahui Health
See details and how to joinNCT07623369 - Phase 1/2Taking peopleStudy of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities
- Where
- Malvern, Nedlands, Saint Leonards
- Age
- 18 years and over
- People
- 244 worldwide
- Run by
- Taiho Pharmaceutical Co., Ltd.
See details and how to joinNCT04683250 - Phase 1/2Taking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Blacktown, Brisbane, Liverpool, Malvern, Melbourne, Nedlands
- Age
- 18 years and over
- People
- 1,109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - Phase 1Not yet taking people in AustraliaA Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.
- Where
- Nedlands
- Age
- 18 years and over
- People
- 16
- Run by
- Radiopharm Theranostics, Ltd
See details and how to joinNCT07272642 - Phase 1/2Taking peopleA Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
- Where
- Melbourne, Sydney
- Age
- 18 years and over
- People
- 270 worldwide
- Run by
- Lumara Bio Oncologics GmbH
See details and how to joinNCT05706129 · EU 2023-504254-35-00 - Phase 1/2Taking peopleA Study of DM005 in Patients With Advanced Solid Tumors
- Where
- Camperdown, North Ryde, South Brisbane
- Age
- 18 years and over
- People
- 208 worldwide
- Run by
- Doma Biopharmaceutical(Suzhou)Co., Ltd.
See details and how to joinNCT06515990 - Phase 3Taking peopleA Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Where
- Ballarat, Bedford Park, Camperdown, St Albans, Subiaco, Townsville, Woolloongabba
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06203210 · EU 2023-509628-16-00 - Phase 1Taking peopleIDOV-Immune for Advanced Solid Tumors
- Where
- Melbourne, Westmead
- Age
- 18 years and over
- People
- 78 worldwide
- Run by
- ViroMissile, Inc.
See details and how to joinNCT06910657 - Phase 1Taking peopleAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- Camperdown, Melbourne, Woodville South
- Age
- 18 years and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113 - Phase 1Taking peopleA Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
- Where
- Brisbane
- Age
- 18 years and over
- People
- 437 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06764771 - Phase 1Taking peopleClinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
- Where
- Adelaide, Clayton, Randwick, Sydney
- Age
- 18 years and over
- People
- 320 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT05142189 · EU 2023-509283-14-00 - Phase 1Taking peopleA Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Where
- Camperdown, Darlinghurst, Melbourne, Nedlands
- Age
- 18 years and over
- People
- 710 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06179160 · EU 2023-507091-47-00 - Phase 2Taking peopleAutologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- Where
- Darlinghurst, Nedlands, Westmead
- Age
- 18 years to 70 years
- People
- 170 worldwide
- Run by
- Iovance Biotherapeutics, Inc.
See details and how to joinNCT04614103 · EU 2024-510778-26-00 - Phase 1Taking peopleSubcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
- Where
- Camperdown, Melbourne, Waratah
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Amgen
See details and how to joinNCT06598306 · EU 2024-511838-12-00 - Phase 1Taking peopleA Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
- Where
- Perth, Sydney
- Age
- 18 years and over
- People
- 146 worldwide
- Run by
- Epkin
See details and how to joinNCT06789172 - No phaseTaking peopleImplementing Surgery School Prehabilitation Using Telehealth
- Where
- Burnie, Heidelberg, Launceston, Melbourne, New Lambton Heights, Perth, Southport, Waratah, Woolloongabba
- Age
- 18 years and over
- People
- 515
- Run by
- University of Melbourne
See details and how to joinNCT06631872 - Phase 1Taking peopleBBO-11818 in Adult Subjects With KRAS Mutant Cancer
- Where
- Melbourne
- Age
- 18 years and over
- People
- 665 worldwide
- Run by
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
See details and how to joinNCT06917079 - Phase 1/2Taking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Adelaide, Camperdown, East Melbourne, Melbourne
- Age
- 12 years and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - Phase 1/2Taking peopleA Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
- Where
- Adelaide, Brisbane, Frankston, Greenslopes, Malvern, Perth, Sydney, Westmead
- Age
- 18 years and over
- People
- 398 worldwide
- Run by
- Hummingbird Bioscience
See details and how to joinNCT05910827 - No phaseTaking peopleMarkerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging
- Where
- Melbourne
- Age
- 18 years and over
- People
- 30
- Run by
- University of Sydney
See details and how to joinNCT04086082 - No phaseTaking peoplePost-Operative Prediction of PulmonarY Function
- Where
- Saint Leonards
- Age
- 18 years and over
- People
- 15
- Run by
- University of Sydney
See details and how to joinNCT06494254 - No phaseNot yet taking people in AustraliaA Master Trial Assessing the Technical Feasibility of First-In-Human Real-Time Image Guided Radiation Therapy Methods
- Where
- Melbourne
- Age
- 18 years and over
- People
- 40
- Run by
- University of Sydney
See details and how to joinNCT06708221 - Phase 1Taking peopleSafety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors
- Where
- Adelaide, Darlinghurst, Melbourne, Nedlands, Randwick, South Brisbane, Waratah
- Age
- 18 years and over
- People
- 60
- Run by
- Myeloid Therapeutics
See details and how to joinNCT07334119 - No phaseTaking peopleRespiratory Adaptive Computed Tomography: Feasibility Study on Real-Time Gated 4DCT for Lung Cancer Radiotherapy
- Where
- Blacktown
- Age
- 18 years and over
- People
- 30
- Run by
- University of Sydney
See details and how to joinNCT05030207